FE 999326
000381
Phase 3 small_molecule active
Quick answer
FE 999326 for Bladder Cancer is a Phase 3 program (small_molecule) at Ferring Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferring Pharmaceuticals
- Indication
- Bladder Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active